4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-25-000831
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 1,500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2025-02-11 | Grant or award · Stock Option (Right to Buy) | +1,500,000 | 1,500,000 | D | ||
Loading xslF345X05/ownership.xml…